carumonam and Respiratory-Tract-Infections

carumonam has been researched along with Respiratory-Tract-Infections* in 2 studies

Trials

1 trial(s) available for carumonam and Respiratory-Tract-Infections

Article	Year
[Clinical evaluation of carumonam in chronic respiratory infections: double-blind study using cefoperazone as a positive control]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1987, Volume: 61, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Cefoperazone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections	1987

Article

Year

[Clinical evaluation of carumonam in chronic respiratory infections: double-blind study using cefoperazone as a positive control].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1987, Volume: 61, Issue:3

Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Cefoperazone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections

1987

Other Studies

1 other study(ies) available for carumonam and Respiratory-Tract-Infections

Article	Year
[Clinical study of carumonam]. The Japanese journal of antibiotics, 1987, Volume: 40, Issue:11 To evaluate the clinical efficacy of carumonam (CRMN, AMA-1080), the drug was used in the treatment of 10 patients including 4 with pneumonia and each with acute tonsillitis, chronic bronchitis, Mycoplasma pneumonia, primary atypical pneumonia (PAP), chronic pyelitis, and acute cystitis. Since beta-lactam antibiotics were not active against Mycoplasma pneumonia and PAP, these diseases were excluded from the clinical efficacy evaluation of CRMN. Responses were excellent in 1 patient and good in 7. Side effects were not observed. The laboratory test recognized slight elevations of GOT, GPT and eosinophilia in 1 patient and a slight leucopenia in another upon the administration of CRMN. Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Female; Humans; Infusions, Intravenous; Lactams; Male; Middle Aged; Respiratory Tract Infections	1987

Article

Year

[Clinical study of carumonam].

The Japanese journal of antibiotics, 1987, Volume: 40, Issue:11

To evaluate the clinical efficacy of carumonam (CRMN, AMA-1080), the drug was used in the treatment of 10 patients including 4 with pneumonia and each with acute tonsillitis, chronic bronchitis, Mycoplasma pneumonia, primary atypical pneumonia (PAP), chronic pyelitis, and acute cystitis. Since beta-lactam antibiotics were not active against Mycoplasma pneumonia and PAP, these diseases were excluded from the clinical efficacy evaluation of CRMN. Responses were excellent in 1 patient and good in 7. Side effects were not observed. The laboratory test recognized slight elevations of GOT, GPT and eosinophilia in 1 patient and a slight leucopenia in another upon the administration of CRMN.

Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Female; Humans; Infusions, Intravenous; Lactams; Male; Middle Aged; Respiratory Tract Infections

1987